Srikar Nagelli - UTU Research Portal

Srikar Nagelli

srikar.nagelli@utu.fi

CIP2A coordinates phosphosignaling, mitosis, and the DNA damage response (2023)
- Trends in Cancer
Nagelli Srikar, Westermarck Jukka
CIP2A is a critical DNA damage response protein that drives basal-like breast cancer (2023) Nagelli Srikar
CIP2A interacts with TopBP1 and drives basal-like breast cancer tumorigenesis (2021)
- Cancer Research
Laine Anni, Nagelli Srikar G., Farrington Caroline, Butt Umar, Cvrljevic Anna N., Vainonen Julia P., Feringa Femke M., Grönroos Tove J., Gautam Prson, Khan Sofia, Sihto Harri, Qiao Xi, Pavic Karolina, Connolly Denise C., Kronqvist Pauliina, Elo Laura L., Maurer Jochen, Wennerberg Krister, Medema Rene H., Joensuu Heikki, Peuhu Emilia, de Visser Karin, Narla Goutham, Westermarck Jukka
Discovery of a Novel CIP2A Variant (NOCIVA) with Clinical Relevance in Predicting TKI Resistance in Myeloid Leukemias (2021)
- Clinical Cancer Research
Mäkelä Eleonora, Pavic Karolina, Varila Taru, Salmenniemi Urpu, Löyttyniemi Eliisa, Nagelli Srikar G., Ammunét Tea, Kähäri Veli-Matti, Clark Richard E., Elo Laura L., Bachanaboyina Venkata Kumari, Lucas Claire M., Itälä-Remes Maija, Westermarck Jukka